Anti-SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021-June 2022.

MLA

Sumner, Kelsey M., et al. “Anti-SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021-June 2022.” The Journal of Infectious Diseases, vol. 230, no. 1, July 2024, pp. 45–54. EBSCOhost, https://doi.org/10.1093/infdis/jiae090.

APA

Sumner, K. M., Yadav, R., Noble, E. K., Sandford, R., Joshi, D., Tartof, S. Y., Wernli, K. J., Martin, E. T., Gaglani, M., Zimmerman, R. K., Talbot, H. K., Grijalva, C. G., Belongia, E. A., Chung, J. R., Rogier, E., Coughlin, M. M., & Flannery, B. (2024). Anti-SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021-June 2022. The Journal of Infectious Diseases, 230(1), 45–54. https://doi.org/10.1093/infdis/jiae090

Chicago

Sumner, Kelsey M, Ruchi Yadav, Emma K Noble, Ryan Sandford, Devyani Joshi, Sara Y Tartof, Karen J Wernli, et al. 2024. “Anti-SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021-June 2022.” The Journal of Infectious Diseases 230 (1): 45–54. doi:10.1093/infdis/jiae090.